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Abstract
The use of non‐human animal models for infection experiments is important
for investigating the infectious processes of human pathogenic bacteria at the
molecular level. Mammals, such as mice and rabbits, are also utilized as ani-
mal infection models, but large numbers of animals are needed for these
experiments, which is costly, and fraught with ethical issues. Various
non‐mammalian animal infection models have been used to investigate the
molecular mechanisms of various human pathogenic bacteria, including
Staphylococcus aureus, Streptococcus pyogenes, and Pseudomonas aeruginosa.
This review discusses the desirable characteristics of non‐mammalian infection
models and describes recent non‐mammalian infection models that utilize
Caenorhabditis elegans, silkworm, fruit fly, zebrafish, two‐spotted cricket,
hornworm, and waxworm.
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1 | INTRODUCTION
Using mice as an animal infection model of anthrax,
Koch first identified Bacillus anthracis as a human pa-
thogen. Because B. anthracis naturally infects mammals
such as cows and sheep as well as humans, it is reason-
able to use a mouse infection model of B. anthracis. Koch
determined three principles, referred to as Koch's pos-
tulates, for identifying infectious disease‐causing patho-
gens. One of these three principles is that a pure cultured
microorganism causes the disease in healthy susceptible
animals. Since Koch's study, several mammals that are
phylogenetically close to humans have been used as
healthy susceptible animals. In the dawning age of in-
fection research around the late 19th century, the aims of
animal infection experiments were to identify the cau-
sative pathogens and toxins, and evaluate antisera and
vaccines. In the present day, genome science has revealed
a vast number of biologic molecules that constitute pa-
thogenic microorganisms and their host animals,
prompting investigations of their functions in infectious
processes. Furthermore, the biomolecules found to be
involved in the infectious processes are new targets for
anti‐infective drugs. Therefore, current infection research
requires a large number of experiments.
Infection experiments using mammals are costly. For
example, an inexpensive mouse strain costs approxi-
mately 10 US dollars per mouse. In addition, the use of
mammals for research purposes is restricted inter-
nationally from an ethical point of view.1 To perform
infection experiments using mammals, research‐planning
documents must adhere to international guidelines and
be approved by the institutional ethics committee. The
high cost and ethical issues regarding the use of mam-
mals for research can mostly be avoided when non‐
mammalian animals are used. Some review articles
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describe a specific non‐mammalian animal model for
infection studies, but few review articles broadly de-
scribing non‐mammalian animal infection models are
available to help researchers select the most appropriate
non‐mammalian model for their specific experimental
purposes. In this review, we summarize the advantages of
non‐mammalian infection models and describe several
non‐mammalian models recently used to study infection.
2 | CRITERIA FOR ANIMAL
INFECTION MODELS
Animals used for infection experiments should satisfy the
following criteria. Researchers must select an animal
species whose characteristics are most suitable for the
experimental purpose.
2.1 | Obtaining animals with
homogeneous conditions
A large number of animals is needed for evaluating the
virulence activity of a bacterial strain. Animals with dif-
ferent conditions, such as maturation, body weight, and
health level, will exhibit different susceptibility to bac-
teria. Thus, ideally, researchers should obtain a large
number of animals with homogeneous conditions. Ani-
mals can be raised in a laboratory or are commercially
available. For insect models, however, researchers can
easily obtain animals whose body weight is almost the
same by selecting animals that underwent molting at
about the same time.
2.2 | Space for breeding and infection
experiment
A large space for breeding and infection experiments
requires a lot of effort to maintain. A small space is de-
sirable to maintain animal health and to perform infec-
tion experiments. Autoclavable and disposable plastic
containers are convenient for infection experiments.
2.2.1 | Injection
For infection experiments, a specific amount of bacterial
solution is injected into a specific part of the animal body.
If the animal is large enough to use a medical syringe and
needle, it is easy to conduct quantitative injection ex-
periments. In addition, animals that can be controlled
without anesthesia or a holding apparatus are easier to
use for infection experiments.
2.3 | Research on host factors
To investigate the host factors involved in infectious
processes, it is important to perform a biochemical ap-
proach by purifying biologic molecules, as well as a ge-
netic approach by creating genetically modified animals.
In the past, genetic modification was performed only in
model organisms such as Caenorhabditis elegans, Droso-
phila melanogaster, and mice. Recently, genome editing
technology has enabled genetic modifications in many
animal species. Small‐sized animals are generally not
suitable for purifying biomolecules due to the small
amount of biologic starting material. But when the target
biomolecules are expressed in high amounts, small‐sized
animals could be used for a biochemical approach.
3 | NON ‐MAMMALS USED AS
INFECTION MODELS
The characteristics of non‐mammals used as infection
models of human pathogenic bacteria are described
below.
3.1 | Caenorhabditis elegans
C. elegans is an important model organism in embryology
in which all cell lineages can be pursued. In the late
1990s, Ausubel et al. began utilizing this animal as an
animal infection model of Pseudomonas aeruginosa.2 This
is the first case in which a non‐mammal was used as an
infection model of a human pathogen. C. elegans is nor-
mally fed Escherichia coli. When C. elegans is fed patho-
genic bacteria such as P. aeruginosa, the C. elegans dies.
There are two known killing mechanisms: toxin secreted
from the bacteria kills the animal and digesting the
bacteria kills the animal.3 When bacterial infection kills
C. elegans, it is difficult to estimate the number of in-
fected bacteria in the C. elegans because the infection
inhibits feeding behavior. Genetic manipulation methods
are well established in C. elegans, enabling genetic ana-
lysis of host factors. Due to its small body size, it is easy to
maintain the worms in a small space, but it is difficult to
inject a bacterial solution into the worm (Table 1).
C. elegans can be obtained from genetic stock centers or
other researchers, and can be proliferated in a laboratory.
C. elegans has been used in infection experiments with
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various human pathogenic bacteria such as S. aureus and
Klebsiella pneumoniae (Table 2).
3.2 | Silkworm (Bombyx mori)
The silkworm is the larva of Bombyx mori, a lepidopteran
insect that has been utilized in the silk industry for more
than 4000 years. In 2002, we found that various human
pathogenic bacteria, including S. aureus, kill silkworms
(Figure 1).4 Because the silkworm has a large body size
and is slow‐moving, it is easy to inject an appropriate
amount of sample solution into the silkworm hemo-
lymph using a 27‐gauge needle and syringe without an-
esthesia5 (Table 1). This accurate injection technique
enables the evaluation of bacterial virulence properties by
determining the median lethal dose.5,6 Skilled re-
searchers can inject 150 silkworms in 1 hr. Silkworm
eggs, larvae, and artificial diets are commercially avail-
able in various regions of the world, including Europe,
the United States, and Japan. Because the silkworm is a
domesticated animal that cannot proliferate in nature
and does not escape from its cage, the silkworm infection
model is suitable for experiments using biohazardous
infectious agents. The silkworm has been used as an in-
fection model of various human pathogenic bacteria such
as P. aeruginosa and S. pyogenes (Table 2).
3.3 | Fruit fly (Drosophila melanogaster)
The fruit fly is used as a model organism for genetic
analysis. The Toll‐like receptor, an important receptor in
the innate immune system, was discovered in a fruit fly
infection model with E. coli. The fruit fly has been used as
an infection model for many human pathogenic bacteria,
including S. aureus.7 To perform infection experiments
using the fruit fly, anesthesia is induced by carbon di-
oxide gas and a needle dipped in bacterial solution is used
to cause injury under a microscope, or the fly can be
injected with bacterial solution using a glass capillary
under a microscope (Table 1).8,9 Biohazard prevention
requires considerable attention, because flies can escape
by flying away. Fruit flies can be obtained from stock
centers or other researchers, and can be proliferated in a
laboratory.
3.4 | Zebrafish (Danio rerio)
The zebrafish is a well‐known aquarium fish and model
organism. The embryo is transparent and thus suitable
for observing organ development. Both adult fish and
embryos are used for infection experiments (Table 1). To
infect an adult fish, the fish is anesthetized with tricaine
and injected with a bacterial solution using a syringe and
a 29‐gauge needle.10 To infect an embryo, the bacterial
solution is injected using a glass capillary under a mi-
croscope.11 The transparency of the embryo enables
real‐time imaging of the infectious process by Myco-
bacterium11 (Table 2). Zebrafish can be purchased from
ornamental fish shops, or the fish strain used for genetic
analysis can be obtained from genetic stock centers or
other researchers. It should be noted that fish experi-
ments now require approval from research ethics
committees.
TABLE 1 Characteristics of non‐mammalian infection models and mouse infection model
Costa Space Injectionb
Research on host factor
Model animal Genetic mutantc Biological material
C. elegans Low Small Difficult Available Small
Silkworm (B. mori) Low Small Easy Non‐available Large
Fruit fly (D. melanogaster) Low Small Difficult Available Small
Zebrafish (D. rerio) Middle Small Normal/Difficultd Available Large
Two‐spotted cricket (G. bimaculatus) Low Small Easy Non‐available Large
Hornworm (M. sexta) Low Small Normal Non‐available Large
Waxworm (G. mellonella) Low Small Normal Non‐available Large
Mouse (M. musculus) High Large Normal Available Large
aLow, less than 1 US dollar/animal; Middle, 1–5 US dollars/animal; High, more than 5 US dollars/animal.
bEasy, requires no anesthesia, holding apparatus, or microscope; Normal, requires anesthesia or holding apparatus, but no microscope; Difficult, requires glass
capillary and microscope.
cAvailable means that genetically modified animals can be obtained from a genetic stock center.
dAdult fish, Normal; embryo, Difficult.
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3.5 | Two‐spotted crickets
Crickets have long been used as model animals of calling
behavior and aggressive behavior. Two‐spotted crickets and
house crickets are easy to purchase and maintain, because
these crickets are captive‐bred as food for reptiles. The two‐
spotted cricket is a tropical insect that can be kept at 37°C,
human body temperature. We examined two‐spotted
crickets as an animal infection model of human patho-
gens and found that human pathogenic bacteria and fungi
kill two‐spotted crickets12,13 (Figure 2). Furthermore, we
revealed that the sensitivity of two‐spotted crickets to S.
aureus and P. aeruginosa is not different between 27°C and
37°C, whereas the sensitivity of two‐spotted crickets to
Listeria monocytogenes is greater at 37°C than at 27°C.12
These findings suggest that two‐spotted crickets do not have
increased sensitivity to all pathogens at a high temperature,
but rather that specific pathogens exhibit increased viru-
lence properties in high temperature conditions. Utilization
of the two‐spotted cricket model allows for comparisons of
the virulence of pathogenic bacteria at low and high tem-
peratures, and identification of temperature‐dependent
virulence mechanisms of bacteria. In infection experi-
ments, two‐spotted crickets are injected with a bacterial
solution using a syringe with a 30‐gauge needle without
anesthesia12 (Table 1).
3.6 | Hornworm (Manduca sexta)
The hornworm is a larva ofM. sexta, a lepidopteran insect
that damages tobacco leaves, and has been used for re-
search on hormones and neurons. Hornworms are
captive‐bred as food for reptiles or fish, and fertilized eggs
FIGURE 1 Silkworm Staphylococcus
aureus infection model. Silkworms are
injected into the hemolymph with
S. aureus (107 CFU/larva) or saline. Images
obtained 3 days after infection are shown.
All the larvae injected with S. aureus died.
TABLE 2 Bacterial species evaluated in non‐mammalian infection models
Bacterial species C. elegans Silkworm Fruit fly Zebrafish Two‐spotted cricket Hornworm Waxworm
Campylobacter jejuni − − − − − − Yes36
Francisella tularensis Yes37 Yes38 Yes9 Yes39 − − Yes40
Legionella pneumophila Yes41 − Yes42 − − − Yes43
Acinetobacter baumannii Yes44 − − Yes45 − − Yes24
Pseudomonas aeruginosa Yes2 Yes4 Yes46 Yes47 Yes12 Yes48 Yes49
Klebsiella pneumoniae Yes50 − Yes51 Yes52 − − Yes53
Shigella sp. Yes54 − − Yes55 − − Yes56
Yersinia pestis Yes57 − − − − − Yes58
Mycobacterium sp. Yes59 Yes60 Yes61 Yes11 − − Yes62
Enterococcus faecalis Yes63 − Yes64 Yes65 − Yes66 Yes67
Staphylococcus aureus Yes63 Yes4 Yes7 Yes68 Yes12 Yes15 Yes69
Streptococcus pyogenes Yes63 Yes26 − Yes10 − − Yes70
Listeria monocytogenes Yes71 Yes72 Yes73 Yes74 Yes12 − Yes75
Bacillus cereus Yes76 Yes77 Yes78 − − − Yes79
− indicates no report available.
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and artificial foods are commercially available (Table 1).
The hornworm was first examined as an animal infection
model of Bacillus cereus, a human pathogenic bacter-
ium14 and subsequently used for evaluating the virulence
factors of other pathogens, such as S. aureus15 and
Streptococcus pneumoniae16 (Table 2). After anesthetiza-
tion by ice, hornworms are injected with bacterial solu-
tion using a Hamilton syringe with a 30‐gauge needle.17
3.7 | Waxworm (Galleria mellonella)
The waxworm is a larva of G. mellonella, which feeds on
honeybee nests. Waxworms are captive‐bred worldwide as
food for amphibians, reptiles, and fish, and are easy to pur-
chase and maintain (Table 1). For injection of waxworms,
the worms are anesthetized on ice and injected using a syr-
inge with a 30‐gauge needle,18,19 or held in a special appa-
ratus and injected.20 Because waxworms can grow at 37°C,21
infection experiments can be performed at 37°C. All human
pathogens that have been examined in the waxworm infec-
tion model at 37°C, including S. aureus,22 Cryptococcus
neoformans,23 and Acinetobacter baumannii,24 exhibited in-
creased killing activity against waxworms at 37°C compared
with a low temperature, raising the possibility that the
waxworm immune system is damaged at 37°C and evalua-
tion of the temperature effects on the virulence properties of
pathogens should be evaluated cautiously in this model. A
number of human pathogenic bacteria have been examined
in the waxworm infection model (Table 2).
4 | COVERAGE OF NON ‐
MAMMALIAN INFECTION MODEL
IN INFECTION RESEARCH
In infection experiments, animals must exhibit sensitivity
against the pathogen. Whether a non‐mammal is
susceptible to a human‐pathogenic bacterium depends on
the conservation of the organ, tissue, cell, and cell sig-
naling involved in the infection process between non‐
mammals and mammals. The innate immune system
constitutes the first defense mechanism against invading
pathogens and is similar in many aspects between
mammals and insects. For example, antimicrobial pep-
tides that act as humoral antimicrobials, Toll‐like re-
ceptors that recognize pathogens by pattern recognition,
and intracellular signaling pathways that are triggered by
Toll‐like receptors are conserved between mammals and
insects.25 In addition, although insect appearance is dis-
tinct from that of mammals, insects have compartments
that function as the blood, gut, liver, kidney, and heart.
Therefore, interactions between the pathogen and host
that depend on conserved biologic systems can be ana-
lyzed in insect infection models. Various human patho-
genic bacteria are analyzed in many insect infection
models (Table 2). We previously reported that S. aureus,
P. aeruginosa, S. pyogenes, and enterohemorrhagic E. coli
kill silkworms4,26 (Table 2), identified the bacterial genes
required for killing silkworms, and revealed that the
identified genes contribute to virulence against mam-
mals.6,26–30 Some of the bacterial genetic mutants with
attenuated killing activity against silkworms are sensitive
to oxidative stress in macrophages, antimicrobial pep-
tides, and complements.31,30 Because bacterial resistance
to the host innate immune system is essential for bac-
terial infection in both mammals and insects, the silk-
worm infection model can be used to evaluate the
virulence properties of human pathogenic bacteria. In
contrast, there are differences between mammals and
silkworms in the host–pathogen interaction. For ex-
ample, neurotoxins for mammals, including botulinum
toxin and morphine, are less toxic to silkworms, although
both alpha and beta hemolysin of S. aureus are toxic to
silkworms.32,33 This difference could be due to the pre-
sence or absence of toxin receptors in silkworms. When
FIGURE 2 Infection model using the two‐spotted cricket. (a) A disposable plastic cage (diameter 130mm×height 100mm) used
for infection experiments with two‐spotted crickets is shown, in which five crickets are grouped together and provided cricket food,
water, and shelter. (b) Two‐spotted crickets were injected with Staphylococcus aureus (108 CFU/cricket) or saline. Images obtained 1 day
after infection are shown. All the crickets injected with S. aureus died.
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pathogens infect animals via mammalian‐specific routes,
non‐mammalian infection models cannot be used to
evaluate bacterial virulence. Recent progress in genome
editing technologies may solve such problems of non‐
mammalian infection models by constructing humanized
non‐mammalian models in future.
Chronic infection is a unique aspect of some hu-
man pathogenic bacteria such as Mycobacterium tu-
berculosis. At present, most non‐mammalian infection
models are used for acute infection by human patho-
genic bacteria, in which bacteria proliferate in he-
molymph or blood and kill animals within 10 days.
Chronic infection experiments using non‐mammalian
models are not well established and challenging. In
the zebrafish model, chronic infection by Myco-
bacterium marinum has been studied as a model of M.
tuberculosis infection in humans. M. marinum infec-
tion in adult zebrafish is prolonged for more than 8
weeks and forms granulomas, a characteristic of
chronic tuberculosis infection.34,35
5 | CONCLUDING REMARKS
This review outlines non‐mammalian infection mod-
els used over the past two decades. In the absence of
an appropriate established infection model among
current infection models, a new animal infection
model must be established to proceed with the infec-
tion research. Most of the non‐mammals mentioned in
this review are utilized as foods for animals such as
reptiles and fish. Food animals are easily maintained
and bred, grow rapidly, have large bodies, and are
inexpensive, which are desirable characteristics for
animal infection models. Various non‐mammalian
species that are used as food animals are good re-
sources for establishing new animal infection models
and will be powerful tools for infection research.
ACKNOWLEDGMENTS
JSPS Grants‐in‐Aid for Scientific Research, Grant/Award
Number: 19H03466, 19K22523, Takeda Science Founda-
tion, and The Ichiro Kanehara Foundation.
CONFLICT OF INTEREST
All authors declare there are no conflicts of interest.
DATA AVAILABILITY STATEMENT
Data sharing not applicable to this article as no datasets




1. Cheluvappa R, Scowen P, Eri R. Ethics of animal research in
human disease remediation, its institutional teaching: and al-
ternatives to animal experimentation. Pharmacol Res Perspect.
2017;5:e00332.
2. Tan MW, Mahajan‐Miklos S, Ausubel FM. Killing of Cae-
norhabditis elegans by Pseudomonas aeruginosa used to model
mammalian bacterial pathogenesis. Proc Natl Acad Sci USA.
1999;96:715‐20.
3. Aballay A, Ausubel FM. Caenorhabditis elegans as a host for
the study of host‐pathogen interactions. Curr Opin Microbiol.
2002;5:97‐101.
4. Kaito C, Akimitsu N, Watanabe H, Sekimizu K. Silkworm
larvae as an animal model of bacterial infection pathogenic to
humans. Microb Pathog. 2002;32:183‐90.
5. Kurokawa K, Kaito C, Sekimizu K. Two‐component signaling
in the virulence of Staphylococcus aureus: a silkworm larvae‐
pathogenic agent infection model of virulence. Methods
Enzymol. 2007;422:233‐44.
6. Miyazaki S, Matsumoto Y, Sekimizu K, Kaito C. Evaluation of
Staphylococcus aureus virulence factors using a silkworm
model. FEMS Microbiol Lett. 2012;326:116‐24.
7. Needham AJ, Kibart M, Crossley H, Ingham PW, Foster SJ.
Drosophila melanogaster as a model host for Staphylococcus
aureus infection. Microbiology. 2004;150:2347‐55.
8. Vodovar N, Acosta C, Lemaitre B, Boccard F. Drosophila: a
polyvalent model to decipher host‐pathogen interactions.
Trends Microbiol. 2004;12:235‐42.
9. Vonkavaara M, Telepnev MV, Ryden P, Sjostedt A, Stoven S.
Drosophila melanogaster as a model for elucidating the patho-
genicity of Francisella tularensis. Cell Microbiol. 2008;10:1327‐38.
10. Neely MN, Pfeifer JD, Caparon M. Streptococcus‐zebrafish model of
bacterial pathogenesis. Infect Immun. 2002;70:3904‐14.
11. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P,
Ramakrishnan L. Real‐time visualization of mycobacterium‐
macrophage interactions leading to initiation of granuloma
formation in zebrafish embryos. Immunity. 2002;17:693‐702.
12. Kochi Y, Miyashita A, Tsuchiya K, Mitsuyama M, Sekimizu K,
Kaito C. A human pathogenic bacterial infection model using
the two‐spotted cricket, Gryllus bimaculatus. FEMS Microbiol
Lett. 2016;363:fnw163.
13. Kochi Y, Matsumoto Y, Sekimizu K, Kaito C. Two‐spotted
cricket as an animal infection model of human pathogenic
fungi. Drug Discov Ther. 2017;11:259‐66.
14. Harvie DR, Vilchez S, Steggles JR, Ellar DJ. Bacillus cereus Fur
regulates iron metabolism and is required for full virulence.
Microbiology. 2005;151:569‐77.
15. Fleming V, Feil E, Sewell AK, Day N, Buckling A, Massey RC.
Agr interference between clinical Staphylococcus aureus strains
in an insect model of virulence. J Bacteriol. 2006;188:7686‐8.
16. Roth A, Reichmann P, Hakenbeck R. The capsule of Strepto-
coccus pneumoniae contributes to virulence in the insect model
Manduca sexta. J Mol Microbiol Biotechnol. 2012;22:326‐34.
17. Hussa E. Rearing and injection of Manduca sexta larvae to
assess bacterial virulence. J Vis Exp. 2012;70:e4295.
18. Bokhari H, Ali A, Noreen Z, Thomson N, Wren BW. Galleria
mellonella is low cost and suitable surrogate host for studying
virulence of human pathogenic Vibrio cholerae. Gene. 2017;
628:1‐7.
590 | KAITO ET AL.
19. Rossoni RD, Ribeiro FC, Dos Santos HFS, et al. Galleria mel-
lonella as an experimental model to study human oral patho-
gens. Arch Oral Biol. 2019;101:13‐22.
20. Dalton JP, Uy B, Swift S, Wiles S. A novel restraint device for
injection of Galleria mellonella larvae that minimizes the risk
of accidental operator needle stick injury. Front Cell Infect
Microbiol. 2017;7:99.
21. Warren LO, Huddleston P. Life history of the greater wax
moth, Galleria mellonella L., in Arkansas. J Kans Entomol Soc.
1962;35:212‐16.
22. Desbois AP, Coote PJ. Wax moth larva (Galleria mellonella): an
in vivo model for assessing the efficacy of antistaphylococcal
agents. J Antimicrob Chemother. 2011;66:1785‐90.
23. Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonella
as a model system to study Cryptococcus neoformans patho-
genesis. Infect Immun. 2005;73:3842‐50.
24. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr,
Mylonakis E. Galleria mellonella as a model system to study
Acinetobacter baumannii pathogenesis and therapeutics.
Antimicrob Agents Chemother. 2009;53:2605‐9.
25. Sheehan G, Garvey A, Croke M, Kavanagh K. Innate humoral
immune defences in mammals and insects: the same, with
differences? Virulence. 2018;9:1625‐39.
26. Kaito C, Kurokawa K, Matsumoto Y, et al. Silkworm patho-
genic bacteria infection model for identification of novel viru-
lence genes. Mol Microbiol. 2005;56:934‐44.
27. Matsumoto Y, Kaito C, Morishita D, Kurokawa K, Sekimizu K.
Regulation of exoprotein gene expression by the Staphylococcus
aureus cvfB gene. Infect Immun. 2007;75:1964‐72.
28. Kyuma T, Kimura S, Hanada Y, Suzuki T, Sekimizu K, Kaito C.
Ribosomal RNA methyltransferases contribute to Staphylo-
coccus aureus virulence. FEBS J. 2015;282:2570‐84.
29. Kaito C, Yoshikai H, Wakamatsu A, et al. Non‐pathogenic
Escherichia coli acquires virulence by mutating a growth‐
essential LPS transporter. PLoS Pathog. 2020;16:e1008469.
30. Miyashita A, Iyoda S, Ishii K, Hamamoto H, Sekimizu K,
Kaito C. Lipopolysaccharide O‐antigen of enterohemorrhagic
Escherichia coli O157: H7 is required for killing both insects
and mammals. FEMS Microbiol Lett. 2012;333:59‐68.
31. Kyuma T, Kizaki H, Ryuno H, Sekimizu K, Kaito C. 16S rRNA
methyltransferase KsgA contributes to oxidative stress re-
sistance and virulence in Staphylococcus aureus. Biochimie.
2015;119:166‐74.
32. Hamamoto H, Tonoike A, Narushima K, Horie R, Sekimizu K.
Silkworm as a model animal to evaluate drug candidate toxicity
and metabolism. Comp Biochem Physiol C Toxicol Pharmacol.
2009;149:334‐9.
33. Hossain MS, Hamamoto H, Matsumoto Y, et al. Use of silk-
worm larvae to study pathogenic bacterial toxins. J Biochem.
2006;140:439‐44.
34. Swaim LE, Connolly LE, Volkman HE, Humbert O, Born DE,
Ramakrishnan L. Mycobacterium marinum infection of adult zeb-
rafish causes caseating granulomatous tuberculosis and is moder-
ated by adaptive immunity. Infect Immun. 2006;74:6108‐17.
35. Van Der Sar AM, Spaink HP, Zakrzewska A, Bitter W,
Meijer AH. Specificity of the zebrafish host transcriptome re-
sponse to acute and chronic mycobacterial infection and the
role of innate and adaptive immune components. Mol
Immunol. 2009;46:2317‐32.
36. Champion OL, Karlyshev AV, Senior NJ, et al. Insect infection
model for Campylobacter jejuni reveals that O‐methyl phosphor-
amidate has insecticidal activity. J Infect Dis. 2010;201:776‐82.
37. Jayamani E, Tharmalingam N, Rajamuthiah R, et al. Char-
acterization of a Francisella tularensis‐Caenorhabditis elegans
pathosystem for the evaluation of therapeutic compounds.
Antimicrob Agents Chemother. 2017;61:e00310‐17.
38. Suzuki J, Uda A, Watanabe K, Shimizu T, Watarai M. Sym-
biosis with Francisella tularensis provides resistance to patho-
gens in the silkworm. Sci Rep. 2016;6:31476.
39. Brudal E, Ulanova LS, E OL, Rishovd AL, Griffiths G, Winther‐
Larsen HC. Establishment of three Francisella infections in
zebrafish embryos at different temperatures. Infect Immun.
2014;82:2180‐94.
40. Aperis G, Fuchs BB, Anderson CA, Warner JE, Calderwood SB,
Mylonakis E. Galleria mellonella as a model host to study in-
fection by the Francisella tularensis live vaccine strain.
Microbes Infect. 2007;9:729‐34.
41. Komura T, Yasui C, Miyamoto H, Nishikawa Y. Caenorhabditis
elegans as an alternative model host for legionella pneumophila,
and protective effects of Bifidobacterium infantis. Appl Environ
Microbiol. 2010;76:4105‐8.
42. Kubori T, Shinzawa N, Kanuka H, Nagai H. Legionella me-
taeffector exploits host proteasome to temporally regulate
cognate effector. PLoS Pathog. 2010;6:e1001216.
43. Harding CR, Schroeder GN, Reynolds S, et al. Legionella
pneumophila pathogenesis in the Galleria mellonella infection
model. Infect Immun. 2012;80:2780‐90.
44. Smith MG, Des Etages SG, Snyder M. Microbial synergy via an
ethanol‐triggered pathway. Mol Cell Biol. 2004;24:3874‐84.
45. Bhuiyan MS, Ellett F, Murray GL, et al. Acinetobacter bau-
mannii phenylacetic acid metabolism influences infection
outcome through a direct effect on neutrophil chemotaxis. Proc
Natl Acad Sci USA. 2016;113:9599‐604.
46. D'Argenio DA, Gallagher LA, Berg CA, Manoil C. Drosophila
as a model host for Pseudomonas aeruginosa infection.
J Bacteriol. 2001;183:1466‐71.
47. Clatworthy AE, Lee JS, Leibman M, Kostun Z, Davidson AJ,
Hung DT. Pseudomonas aeruginosa infection of zebrafish in-
volves both host and pathogen determinants. Infect Immun.
2009;77:1293‐303.
48. Del Campo ML, Halitschke R, Short SM, Lazzaro BP, Kessler A.
Dietary plant phenolic improves survival of bacterial infection in
Manduca sexta caterpillars. Entomol Exp Appl. 2013;146:321‐31.
49. Hendrickson EL, Plotnikova J, Mahajan‐Miklos S, Rahme LG,
Ausubel FM. Differential roles of the Pseudomonas aeruginosa
PA14 rpoN gene in pathogenicity in plants, nematodes, insects,
and mice. J Bacteriol. 2001;183:7126‐34.
50. Fuursted K, Scholer L, Hansen F, et al. Virulence of a Klebsiella
pneumoniae strain carrying the New Delhi metallo‐beta‐
lactamase‐1 (NDM‐1). Microbes Infect. 2012;14:155‐8.
51. Lee H, Baek JY, Kim SY, et al. Comparison of virulence be-
tween matt and mucoid colonies of Klebsiella pneumoniae co-
producing NDM‐1 and OXA‐232 isolated from a single patient.
J Microbiol. 2018;56:665‐72.
52. Cheepurupalli L, Raman T, Rathore SS, Ramakrishnan J.
Bioactive molecule from Streptomyces sp. mitigates MDR
Klebsiella pneumoniae in Zebrafish infection model. Front
Microbiol. 2017;8:614.
KAITO ET AL. | 591
53. Insua JL, Llobet E, Moranta D, et al. Modeling Klebsiella
pneumoniae pathogenesis by infection of the wax moth Galleria
mellonella. Infect Immun. 2013;81:3552‐65.
54. Burton EA, Pendergast AM, Aballay A. The Caenorhabditis
elegans ABL‐1 tyrosine kinase is required for Shigella flexneri
pathogenesis. Appl Environ Microbiol. 2006;72:5043‐51.
55. Mostowy S, Boucontet L, Mazon Moya MJ, et al. The zebrafish
as a new model for the in vivo study of Shigella flexneri inter-
action with phagocytes and bacterial autophagy. PLoS Pathog.
2013;9:e1003588.
56. Mahmoud RY, Li W, Eldomany RA, Emara M, Yu J. The
Shigella ProU system is required for osmotic tolerance and
virulence. Virulence. 2017;8:362‐74.
57. Joshua GWP, Karlyshev AV, Smith MP, Isherwood KE,
Titball RW, Wren BW. A Caenorhabditis elegans model of
Yersinia infection: biofilm formation on a biotic surface.
Microbiology. 2003;149:3221‐29.
58. Erickson DL, Russell CW, Johnson KL, Hileman T, Stewart RM.
PhoP and OxyR transcriptional regulators contribute to Yersinia
pestis virulence and survival within Galleria mellonella. Microb
Pathog. 2011;51:389‐95.
59. Everman JL, Ziaie NR, Bechler J, Bermudez LE. Establishing
Caenorhabditis elegans as a model for Mycobacterium avium
subspecies hominissuis infection and intestinal colonization.
Biol Open. 2015;4:1330‐5.
60. Yagi A, Uchida R, Hamamoto H, Sekimizu K, Kimura KI,
Tomoda H. Anti‐Mycobacterium activity of microbial peptides
in a silkworm infection model with Mycobacterium smegmatis.
J Antibiot. 2017;70:685‐90.
61. Dionne MS, Ghori N, Schneider DS. Drosophila melanogaster is
a genetically tractable model host for Mycobacterium marinum.
Infect Immun. 2003;71:3540‐50.
62. Rwegasila E, Mubofu EB, Nyandoro SS, Erasto P, Munissi JJ.
Preparation, characterization and in vivo antimycobacterial
studies of panchovillin‐chitosan nanocomposites. Int J Mol Sci.
2016;17:1559.
63. Garsin DA, Sifri CD, Mylonakis E, et al. A simple model host
for identifying Gram‐positive virulence factors. Proc Natl Acad
Sci USA. 2001;98:10892‐7.
64. Cox CR, Gilmore MS. Native microbial colonization of Droso-
phila melanogaster and its use as a model of Enterococcus fae-
calis pathogenesis. Infect Immun. 2007;75:1565‐76.
65. Prajsnar TK, Renshaw SA, Ogryzko NV, Foster SJ, Serror P,
Mesnage S. Zebrafish as a novel vertebrate model to dissect
enterococcal pathogenesis. Infect Immun. 2013;81:4271‐9.
66. Mason KL, Stepien TA, Blum JE, et al. From commensal to
pathogen: translocation of Enterococcus faecalis from the mid-
gut to the hemocoel of Manduca sexta. mBio. 2011;2:e00065‐11.
67. Park SY, Kim KM, Lee JH, Seo SJ, Lee IH. Extracellular gelatinase
of Enterococcus faecalis destroys a defense system in insect hemo-
lymph and human serum. Infect Immun. 2007;75:1861‐9.
68. Prajsnar TK, Cunliffe VT, Foster SJ, Renshaw SA. A novel
vertebrate model of Staphylococcus aureus infection reveals
phagocyte‐dependent resistance of zebrafish to non‐host spe-
cialized pathogens. Cell Microbiol. 2008;10:2312‐25.
69. Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr,
Eliopoulos GM. Reduced susceptibility to vancomycin influ-
ences pathogenicity in Staphylococcus aureus infection. J Infect
Dis. 2009;199:532‐6.
70. Olsen RJ, Watkins ME, Cantu CC, Beres SB, Musser JM.
Virulence of serotype M3 Group A Streptococcus strains in wax
worms (Galleria mellonella larvae). Virulence. 2011;2:111‐9.
71. Thomsen LE, Slutz SS, Tan MW, Ingmer H. Caenorhabditis
elegans is a model host for Listeria monocytogenes. Appl
Environ Microbiol. 2006;72:1700‐1.
72. Castillo Y, Suzuki J, Watanabe K, Shimizu T, Watarai M. Effect
of vitamin A on Listeria monocytogenes infection in a silkworm
model. PLoS One. 2016;11:e0163747.
73. Mansfield BE, Dionne MS, Schneider DS, Freitag NE. Ex-
ploration of host‐pathogen interactions using Listeria mono-
cytogenes and Drosophila melanogaster. Cell Microbiol. 2003;5:
901‐11.
74. Levraud JP, Disson O, Kissa K, et al. Real‐time observation of
listeria monocytogenes‐phagocyte interactions in living zebra-
fish larvae. Infect Immun. 2009;77:3651‐60.
75. Mukherjee K, Altincicek B, Hain T, Domann E, Vilcinskas A,
Chakraborty T. Galleria mellonella as a model system for
studying Listeria pathogenesis. Appl Environ Microbiol. 2010;
76:310‐7.
76. Rae R, Iatsenko I, Witte H, Sommer RJ. A subset of naturally
isolated Bacillus strains show extreme virulence to the free‐
living nematodes Caenorhabditis elegans and Pristionchus pa-
cificus. Environ Microbiol. 2010;12:3007‐21.
77. Usui K, Miyazaki S, Kaito C, Sekimizu K. Purification of a soil
bacteria exotoxin using silkworm toxicity to measure specific
activity. Microb Pathog. 2009;46:59‐62.
78. Ma J, Benson AK, Kachman SD, Hu Z, Harshman LG. Droso-
phila melanogaster selection for survival of Bacillus cereus in-
fection: life history trait indirect responses. Int J Evol Biol.
2012;2012:935970.
79. Salamitou S, Ramisse F, Brehelin M, et al. The plcR regulon is
involved in the opportunistic properties of Bacillus thur-
ingiensis and Bacillus cereus in mice and insects. Microbiology.
2000;146:2825‐32. 2000.
How to cite this article: Kaito C, Murakami K,
Imai L, Furuta K. Animal infection models using non‐
mammals. Microbiology and Immunology. 2020;64:
585–592. https://doi.org/10.1111/1348-0421.12834
592 | KAITO ET AL.
